ATE323693T1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents
Calciumkanalantagonisten vom n-typ zur behandlung von schmerzenInfo
- Publication number
- ATE323693T1 ATE323693T1 AT01981239T AT01981239T ATE323693T1 AT E323693 T1 ATE323693 T1 AT E323693T1 AT 01981239 T AT01981239 T AT 01981239T AT 01981239 T AT01981239 T AT 01981239T AT E323693 T1 ATE323693 T1 AT E323693T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- pain
- calcium channel
- type calcium
- channel antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0004053A SE0004053D0 (sv) | 2000-11-06 | 2000-11-06 | N-type calcium channel antagonists for the treatment of pain |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE323693T1 true ATE323693T1 (de) | 2006-05-15 |
Family
ID=20281713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01981239T ATE323693T1 (de) | 2000-11-06 | 2001-10-31 | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen |
Country Status (9)
Country | Link |
---|---|
US (1) | US6815447B2 (de) |
EP (1) | EP1339706B1 (de) |
JP (1) | JP2004513125A (de) |
AT (1) | ATE323693T1 (de) |
AU (1) | AU2002212894A1 (de) |
DE (1) | DE60118956T2 (de) |
ES (1) | ES2261496T3 (de) |
SE (1) | SE0004053D0 (de) |
WO (1) | WO2002036586A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040259866A1 (en) * | 1998-06-30 | 2004-12-23 | Snutch Terrance P. | Calcium channel blockers comprising two benzhydril moieties |
WO2003099284A1 (en) | 2002-05-22 | 2003-12-04 | Amgen Inc. | Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
MXPA05001456A (es) * | 2002-08-08 | 2005-06-06 | Amgen Inc | Ligandos del receptor vanilloide y su uso en tratamientos. |
US7419984B2 (en) * | 2002-10-17 | 2008-09-02 | Cell Therapeutics, Inc. | Pyrimidines and uses thereof |
CA2507100C (en) | 2002-11-21 | 2012-10-09 | Chiron Corporation | 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
JP4691041B2 (ja) * | 2003-11-20 | 2011-06-01 | チルドレンズ ホスピタル メディカル センター | Gtpアーゼ阻害剤および使用方法 |
US7301022B2 (en) | 2005-02-15 | 2007-11-27 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
WO2006105670A1 (en) * | 2005-04-08 | 2006-10-12 | Neuromed Pharmaceuticals Ltd. | Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
US8362021B2 (en) * | 2006-05-11 | 2013-01-29 | Zalicus Pharmaceuticals Ltd. | Method for increasing the bioavailability of benzhydryl piperazine containing compounds |
CA2675558A1 (en) | 2007-02-06 | 2008-08-14 | Novartis Ag | Pi 3-kinase inhibitors and methods of their use |
BR112012021656A2 (pt) * | 2010-03-04 | 2017-02-07 | Merck Sharp & Dohme | composto, uso do mesmo, e, composição farmacêutica |
MX2012010188A (es) * | 2010-03-04 | 2012-10-03 | Merck Sharp & Dohme | Inhibidores de catecol o-metil transferasa y su uso en el tratamiento de transtornos psicoticos. |
EP2542076B1 (de) | 2010-03-04 | 2021-01-13 | Merck Sharp & Dohme Corp. | Hemmer der catechol-o-methyl-transferase und ihre verwendung bei der behandlung psychotischer störungen |
US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
US8591944B2 (en) | 2011-03-08 | 2013-11-26 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
PE20141581A1 (es) | 2011-09-27 | 2014-11-14 | Novartis Ag | 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante |
UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
EA028033B1 (ru) | 2013-03-14 | 2017-09-29 | Новартис Аг | 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантного idh |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB794043A (en) * | 1955-06-03 | 1958-04-30 | Ici Ltd | New quinoline derivatives |
BR9909666A (pt) | 1998-03-26 | 2001-09-11 | Japan Tobacco Inc | Derivados de amida e antagonistas de nociceptina |
-
2000
- 2000-11-06 SE SE0004053A patent/SE0004053D0/xx unknown
-
2001
- 2001-10-31 ES ES01981239T patent/ES2261496T3/es not_active Expired - Lifetime
- 2001-10-31 JP JP2002539345A patent/JP2004513125A/ja not_active Ceased
- 2001-10-31 US US10/415,785 patent/US6815447B2/en not_active Expired - Fee Related
- 2001-10-31 DE DE60118956T patent/DE60118956T2/de not_active Expired - Fee Related
- 2001-10-31 AT AT01981239T patent/ATE323693T1/de not_active IP Right Cessation
- 2001-10-31 EP EP01981239A patent/EP1339706B1/de not_active Expired - Lifetime
- 2001-10-31 AU AU2002212894A patent/AU2002212894A1/en not_active Abandoned
- 2001-10-31 WO PCT/SE2001/002388 patent/WO2002036586A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1339706A1 (de) | 2003-09-03 |
JP2004513125A (ja) | 2004-04-30 |
DE60118956D1 (de) | 2006-05-24 |
SE0004053D0 (sv) | 2000-11-06 |
DE60118956T2 (de) | 2007-03-15 |
WO2002036586A1 (en) | 2002-05-10 |
US6815447B2 (en) | 2004-11-09 |
US20040058945A1 (en) | 2004-03-25 |
AU2002212894A1 (en) | 2002-05-15 |
ES2261496T3 (es) | 2006-11-16 |
EP1339706B1 (de) | 2006-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE323693T1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
ATE296094T1 (de) | Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen | |
DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
CA2366932A1 (en) | Cyclic protein tyrosine kinase inhibitors | |
DE60135732D1 (de) | Topoisomerasehemmern zur behandlung von chirurgischen verklebungen | |
ATE284690T1 (de) | Antithrombotische diamine | |
DE502005008058D1 (de) | Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen | |
ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
DE60035057D1 (de) | CD40 Antagonist zur Behandlung von Psoriasis | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
DE60204232D1 (de) | Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen | |
DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
SE0302139D0 (sv) | Novel compounds | |
CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
SE0004054D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
SE9802208D0 (sv) | Novel compounds | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
SE0003476D0 (sv) | Compounds | |
SE0303280D0 (sv) | Novel compounds | |
ATE421502T1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
SE9802209D0 (sv) | Novel compounds | |
SE0004055D0 (sv) | N-type calcium channel antagonists for the treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |